Methods: To determine whether ECD can relieve lipid accumulation and insulin resistance (IR) in liver cells, NAFLD and IR cell models were established by treating HepG2 cells with free fatty acids and an overdose of insulin, respectively. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.